<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In order to assess the prevalence of venocclusive disease in autopsied recipients of bone marrow transplantation, we reviewed coded liver histology from 204 consecutive autopsied recipients transplanted for <z:hpo ids='HP_0001909'>leukemia</z:hpo> (142), other <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> (5), or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (57) </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-seven patients with <z:hpo ids='HP_0001909'>leukemia</z:hpo>, 2 with <z:mp ids='MP_0002038'>carcinoma</z:mp>, and 3 with <z:mpath ids='MPATH_58'>aplasia</z:mpath> had venocclusive disease and survived 2-86 days post-transplant </plain></SENT>
<SENT sid="2" pm="."><plain>Early lesions showed subintimal <z:hpo ids='HP_0000969'>edema</z:hpo> and <z:mp ids='MP_0001914'>hemorrhage</z:mp> within small central venules and centrilobular <z:mpath ids='MPATH_107'>congestion</z:mpath> with hepatocyte degeneration </plain></SENT>
<SENT sid="3" pm="."><plain>Later lesions showed subtotal to complete fibrous obliteration of the central venule lumina and centrilobular sinusoidal <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Thirteen patients had a subclinical course, and 19 were symptomatic </plain></SENT>
<SENT sid="5" pm="."><plain>Venocclusive disease was life-threatening or lethal in 13 </plain></SENT>
<SENT sid="6" pm="."><plain>Typical symptoms developed 1-3 wk post-transplant and consisted of sudden <z:mp ids='MP_0005456'>weight gain</z:mp>, hepatic enlargement, <z:hpo ids='HP_0001541'>ascites</z:hpo>, high <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, and <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Statistical analyses showed a significantly higher prevalence of venocclusive disease associated with transplantation for <z:hpo ids='HP_0001909'>leukemia</z:hpo> (P = 0.014), pretransplant conditioning with more rigorous chemoradiotherapy regimens (P &lt; 0.001) and three- to fourfold increase of venocclusive disease in patients whose conditioning included dimethyl <z:chebi fb="0" ids="28901">busulfan</z:chebi> (P &lt; 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>Abnormal liver tests before transplant were also more prevalent among patients with venocclusive disease </plain></SENT>
<SENT sid="9" pm="."><plain>No factors predicted the clinical outcome of established venocclusive disease </plain></SENT>
<SENT sid="10" pm="."><plain>Venocclusive disease showed no association with hepatic <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> even among prolonged cases with severe periportal <z:hpo ids='HP_0012115'>hepatitis</z:hpo> and <z:hpo ids='HP_0001396'>cholestasis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Other centrilobular lesions (hepatocyte degeneration, sinusoidal <z:mp ids='MP_0003045'>fibrosis</z:mp>, and <z:e sem="disease" ids="C0333494" disease_type="Disease or Syndrome" abbrv="">phlebosclerosis</z:e>) were identified in 23 patients </plain></SENT>
<SENT sid="12" pm="."><plain>These non-specific changes may occur with <z:hpo ids='HP_0006562'>viral hepatitis</z:hpo>, <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> or chemoradiotherapy effects </plain></SENT>
</text></document>